Listed

Ernexa Therapeutics Inc.

ERNANasdaqCIK 748592HealthcareFiscal year ends Dec 31

Reports and events: 422 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Ernexa Therapeutics Inc., Reports and events
FiledFormWhat it isAccession number
2021-04-1617:20 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-21-013151
2021-04-1517:20 ET8-K1.01 Entry into a material agreement0001140361-21-012968
2021-04-0717:18 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-21-012036
2021-03-3117:18 ET8-K2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-21-011095
2021-03-2317:28 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-006655
2021-03-1716:30 ETSC 13D/AOwnership report, active investor, amended0001214659-21-003229
2021-03-1616:30 ETSC 13D/AOwnership report, active investor, amended0001214659-21-003181
2021-03-1619:39 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-006033
2021-03-1117:07 ET10-KAnnual reportPeriod 2020-12-310001493152-21-005827
2021-03-0807:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-005525
2021-02-2616:32 ET8-K8.01 Other events0001493152-21-004937
2021-02-2507:02 ET8-K8.01 Other events0001493152-21-004770
2021-02-2216:30 ETSC 13D/AOwnership report, active investor, amended0001214659-21-002194
2021-02-0916:32 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-003076
2021-02-0418:28 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-002556
2021-01-2916:25 ETSC 13DOwnership report, active investor0001214659-21-000983
2021-01-1517:22 ET8-K1.01 Entry into a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits0001493152-21-001197
2020-11-2307:02 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-20-022176
2020-11-1317:00 ET10-QQuarterly reportPeriod 2020-09-300001493152-20-021342
2020-11-1306:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-20-021217
2020-11-0508:00 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-20-020534
2020-09-1817:19 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-018033
2020-08-1817:12 ETSC 13D/AOwnership report, active investor, amended0001213900-20-022708
2020-08-1417:16 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-015948
2020-08-1306:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-015415
2020-08-1216:55 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001493152-20-015356
2020-08-0718:47 ET10-QQuarterly reportPeriod 2020-06-300001493152-20-014994
2020-08-0706:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-20-014915
2020-07-0108:00 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001493152-20-012355
2020-06-1706:30 ET8-K8.01 Other events0001493152-20-011316
2020-06-1516:30 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001493152-20-011179
2020-06-1506:03 ETSC 13D/AOwnership report, active investor, amended0001493152-20-011129
2020-06-0413:56 ETSC 13D/AOwnership report, active investor, amended0001493152-20-010546
2020-06-0216:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-20-010400
2020-05-2016:16 ET10-QQuarterly reportPeriod 2020-03-310001493152-20-009524
2020-05-1916:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-20-009409
2020-04-2717:00 ET10-K/AAnnual report, amendedPeriod 2019-12-310001493152-20-007162
2020-04-2116:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-006840
2020-04-0316:10 ET8-K5.02 Departure or appointment of officers or directors0001493152-20-005788
2020-03-3016:15 ET8-K3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-005216
2020-03-1916:18 ET10-KAnnual reportPeriod 2019-12-310001493152-20-004343
2020-03-1716:20 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-20-004153
2020-01-1516:15 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-000627
2020-01-0816:57 ETSC 13D/AOwnership report, active investor, amended0001062993-20-000077
2019-11-2608:35 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-19-018405
2019-11-0116:11 ET10-QQuarterly reportPeriod 2019-09-300001493152-19-016324
2019-10-3016:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-19-016200
2019-09-1716:40 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-19-014223
2019-09-0306:35 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-19-013592
2019-08-1216:31 ET10-QQuarterly reportPeriod 2019-06-300001493152-19-012078

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.